ArticleBMJ open2025

Rationale and design of the AlloFIST trial: a phase I/IIa study to evaluate dose escalation of allogeneic adipose-derived stroma/stem cells for the treatment of Crohn's fistula.

Etienne Buscail et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.